Opioid Victims Face Setbacks in Purdue Settlement Payouts

A major opioid litigation settlement involving Purdue Pharma, which affects nearly 140,000 claimants, faces setbacks following Supreme Court rulings. Investigative reports reveal that the new $7.4 billion bankruptcy plan will exclude tens of thousands of original applicants. Key changes include slashing estimated payouts and eliminating the ability for victims to submit sworn affidavits as proof of purchase, a provision used in other major bankruptcy cases. Victims express deep frustration over these complex legal shifts and the difficulty of proving historical drug use without physical records.